In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents

In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers Posaconazole Prophylaxis in Experimental Systemic Zygomycosis In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp In Vitro and In Vivo Antifungal Susceptibilities of the Mucoralean Fungus Cunninghamella Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing Susceptibility Testing and Molecular Classification of Paecilomyces spp Posaconazole Enhances the Activity of Amphotericin B against Aspergillus Hyphae In Vitro